China has closed thousands of manufacturing plants as it tries to reduce air pollution, and one pharma company says it has created supply problems.
Switzerland-based Ferring Pharmaceuticals will a new biologics manufacturing site over the next three years.
After a year of remediation, an Indian drugmaker has worked its way out from under an FDA warning letter issued for its sterile injectables operation.
A recently released FDA document shows that Pfizer's troubled fill-finish plant in Kansas was cited for continuing to repeat mistakes already cited by the…
Pfizer this week unveiled its $150 million expansion project in Michigan and is ready to hire about 200 employees.
Celgene has completed the first phase of a new manufacturing facility to produce the CAR-T drug candidate it is developing with partner Bluebird Bio.
The FDA has issued a warning letter to a Bayer finished products plant in Germany, where it says poor cleaning led to product cross-contamination.
A Merck manufacturing site in Ireland that was slated to close has been saved by the drugmaker’s hot-selling cancer drug Keytruda.
ImmunoGen will turn to contractors for its manufacturing needs, a move that will mean a small facility will close and 20 workers will be let go.
Novartis has started the clock ticking for some of the 450 employees at a Colorado plant which it is closing as part of its generics consolidation.